Dr Davidson Ateh (co-founder and CEO) is an entrepreneur operating in the life sciences. He has an interdisciplinary scientific background in bioengineering and was a past recipient of the prestigious Royal Society of Edinburgh/BBSRC Enterprise Fellowship.

Dr Keith Powell (Chairman) has been in biotech since it started. He started at GSK and ICI/Zeneca leading several large groups, then joined Maxygen on the West Coast of the USA, growing a business that eventually spun out as “Codexis”. On his return to the UK he worked with the Bloomsbury BioSeed Fund and Longbow Capital leading portfolio companies including Polytherics. He is currently Chairman of Domainex and Canbex.

Jo is the NHS National Clinical Director of Pathology, Director of Academic Health Sciences (and Consultant Histopathologist) at Barts Health NHS Trust and Professor of Pathology at Queen Mary University of London. She has a track record running a large NHS Trust Division (£89 million budget per annum), delivering and commissioning major projects. She was part of the assessment team on early stage technologies for Nikko Principal Investments.